VaxigripTetra

Ingredient

A/Victoria/2570/2019 (H1N1)pdm09 – like strain (A/Victoria/2570/2019, IVR-215)
A/Hong Kong/2671/2019 (H3N2) – like strain (A/Hong Kong/2671/2019, IVR-208)
B/Washington/02/2019 – like strain (B/Washington/02/2019, wild type)
B/Phuket/3073/2013 – like strain (B/Phuket/3073/2013, wild type)

Content

Indication

the prevention of influenza disease caused by the two influenza A virus
subtypes and the two influenza B virus types contained in the vaccine for:
– active immunisation of adults, including pregnant women, and children from 6 months of age.
– passive protection of infants less than 6 months of age and born to women vaccinated during
pregnancy